1 January 2021 in Clinical Nutrition Research
Tangestani H, et al. Clin Nutr Res. 2021 Jul;10(3):181-191. https://doi.org/10.7762/cnr.2021.10.3.181
9 July 2024 in BMC Public Health
Background: Cardiovascular diseases (CVDs) are the primary cause of mortality globally. The prevalence of obesity is rising worldwide; there seems to be a significant positive association between obesity and CVDs. The distribution of fat in the abdominal area in the form of visceral (VAT) or subcutaneous adipose tissue (SAT) affects the risk of CVDs. The aim of the present study was to conduct a systematic review of the available literature regarding the association between the VAT-to-SAT ratio and CVDs. Methods: A comprehensive search strategy was used to retrieve all human observational studies indexed in PubMed, Scopus and Google Scholar databases/search engines (from Jan 2000 up to Oct 2023). The VAT-to-SAT or SAT-to-VAT ratio was an independent variable and various cardiovascular diseases, including hypertension, atherosclerosis, coronary heart disease, cerebrovascular disease and heart failure, were considered as outcomes of interest. Results: Out of 1173 initial studies, 910 papers were screened. Based on the inclusion criteria, 883 papers were excluded. Finally, 27 papers (18 cross-sectional and 9 cohort studies) published between 2010 and 2023 which met the inclusion criteria were reviewed. Conclusions: The distribution of abdominal fat seems to be associated with the risk of CVDs; the majority of the evidence suggests that a higher abdominal VAT-to-SAT ratio is associated with the development of CVDs. Therefore, this ratio can be used as a prognostic indicator for CVDs. Trial registration: Not applicable.
1 January 2024 in Clinical Nutrition Research
Saadatmand S, et al. Clin Nutr Res. 2024 Apr;13(2):139-147. https://doi.org/10.7762/cnr.2024.13.2.139
1 January 2021 in Clinical Nutrition Research
Tangestani H, et al. Clin Nutr Res. 2021 Jan;10(1):48-58. https://doi.org/10.7762/cnr.2021.10.1.48
22 July 2020 in Nutrition & Food Science
Purpose: Data on relationship between dietary intake of sodium and non-alcoholic fatty liver disease (NAFLD) risk are scarce. This paper aims to find the possible association between sodium intake and NAFLD. Design/methodology/approach: This is a case-control study on NAFLD patients proven by a gastroenterologist using Fibroscan, and age-matched controls. Dietary intakes were assessed using a valid and reliable food frequency questionnaire. Findings: In the multivariable-adjusted model, after adjustment for potential confounding variables, participants in the highest tertile of sodium intake had a greater risk of developing NAFLD (OR= 2.42; 95% CI: 1.13–5.15) compared to those in the lowest tertile of sodium intake (p-value = 0.023). In sub-analysis, subjects with BMI ≥ 25 in the third tertile of sodium intake had higher risk of NAFLD compared to those in the lowest tertile of sodium intake [(OR: 3.95; 95% CI: 1.75–8.90), (p-value = 0.001)]. However, no significant association was found between tertiles of energy-adjusted daily sodium intake and NAFLD prevalence risk in participants with BMI < 25. Originality/value: The findings revealed that higher sodium intake is related with a higher prevalence of NAFLD, an association that can be partly mediated through obesity.
14 June 2021 in EXCLI Journal
The prevalence of non-alcoholic fatty liver disease (NAFLD) has significantly risen all around the world. Although visceral fat mass has been identified as an independent risk factor for NAFLD, the association of other ectopic fat depots, such as Epicardial adipose tissue (EAT), with the disease has not been fully elucidated. The aim of the current study was to systematically review all available human studies conducted on the associations between EAT and NAFLD. All human studies published in English, which examined the association between the thickness or the volume of EAT and the incidence of NAFLD were systematically searched on PubMed, Scopus, and Google Scholar search engines, from inception up to April 2021. Eighteen studies that met inclusion criteria were included in the final review. A total of 86 studies were found through searching the databases. After excluding duplicates, seventy six remained studies were scanned by title and abstract, out of which, 58 were excluded. Finally, eighteen articles (thirteen cross-sectional studies and five case-control studies) published between 2008 and 2021, were included in the review. According to the results of the reviewed articles, EAT was associated with the presence and progression of NAFLD. Furthermore, NAFLD patients with thicker EAT may need a more intensive hepatic follow-up. However, we suggest further investigation to find out the underlying mechanisms describing the observed association.